Literature DB >> 16284284

Molecular basis for subdividing hereditary colon cancer?

W M Grady1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16284284      PMCID： PMC1774772          DOI： 10.1136/gut.2005.073221

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  58 in total

Review 1.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

2.  Cancer family "G" revisited: 1895-1970.

Authors:  H T Lynch; A J Krush
Journal:  Cancer       Date:  1971-06       Impact factor: 6.860

Review 3.  Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma.

Authors:  M S Rhyu
Journal:  J Natl Cancer Inst       Date:  1996-03-06       Impact factor: 13.506

4.  Sequence analysis of the mismatch repair gene hMSH6 in the germline of patients with familial and sporadic colorectal cancer.

Authors:  J Plaschke; C Kruppa; R Tischler; T Bocker; S Pistorius; H Dralle; J Rüschoff; H D Saeger; R Fishel; H K Schackert
Journal:  Int J Cancer       Date:  2000-03-01       Impact factor: 7.396

5.  Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.

Authors:  Hidewaki Nakagawa; Janet C Lockman; Wendy L Frankel; Heather Hampel; Kelle Steenblock; Lawrence J Burgart; Stephen N Thibodeau; Albert de la Chapelle
Journal:  Cancer Res       Date:  2004-07-15       Impact factor: 12.701

6.  Family cancer histories predictive of a high risk of hereditary non-polyposis colorectal cancer associate significantly with a genomic rearrangement in hMSH2 or hMLH1.

Authors:  P J Ainsworth; D Koscinski; B P Fraser; J A Stuart
Journal:  Clin Genet       Date:  2004-09       Impact factor: 4.438

7.  p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population.

Authors:  J Shawn Jones; Xuedong Chi; Xiangjun Gu; Patrick M Lynch; Christopher I Amos; Marsha L Frazier
Journal:  Clin Cancer Res       Date:  2004-09-01       Impact factor: 12.531

8.  The Lynch syndrome II and urological malignancies.

Authors:  H T Lynch; J A Ens; J F Lynch
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

9.  BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.

Authors:  E Domingo; P Laiho; M Ollikainen; M Pinto; L Wang; A J French; J Westra; T Frebourg; E Espín; M Armengol; R Hamelin; H Yamamoto; R M W Hofstra; R Seruca; A Lindblom; P Peltomäki; S N Thibodeau; L A Aaltonen; S Schwartz
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

10.  Heterozygous TGFBR2 mutations in Marfan syndrome.

Authors:  Takeshi Mizuguchi; Gwenaëlle Collod-Beroud; Takushi Akiyama; Marianne Abifadel; Naoki Harada; Takayuki Morisaki; Delphine Allard; Mathilde Varret; Mireille Claustres; Hiroko Morisaki; Makoto Ihara; Akira Kinoshita; Koh-ichiro Yoshiura; Claudine Junien; Tadashi Kajii; Guillaume Jondeau; Tohru Ohta; Tatsuya Kishino; Yoichi Furukawa; Yusuke Nakamura; Norio Niikawa; Catherine Boileau; Naomichi Matsumoto
Journal:  Nat Genet       Date:  2004-07-04       Impact factor: 38.330
View more
  5 in total

Review 1.  Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification.

Authors:  Mukesh Verma; Daniela Seminara; Fernando J Arena; Christy John; Kumiko Iwamoto; Virginia Hartmuller
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

2.  Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans.

Authors:  Krishan Kumar; Hassan Brim; Francis Giardiello; Duane T Smoot; Mehdi Nouraie; Edward L Lee; Hassan Ashktorab
Journal:  Clin Cancer Res       Date:  2009-02-03       Impact factor: 12.531

3.  Precancerous lesions in colorectal cancer.

Authors:  Fayez Sandouk; Feras Al Jerf; M H D Bassel Al-Halabi
Journal:  Gastroenterol Res Pract       Date:  2013-05-14       Impact factor: 2.260

4.  Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study.

Authors:  Hassan Brim; Pooneh Mokarram; Fakhraddin Naghibalhossaini; Mehdi Saberi-Firoozi; Mansour Al-Mandhari; Kamla Al-Mawaly; Rayhaneh Al-Mjeni; Abeer Al-Sayegh; Sandy Raeburn; Edward Lee; Francis Giardiello; Duane T Smoot; Alexander Vilkin; C Richard Boland; Ajay Goel; Mitra Hafezi; Mehdi Nouraie; Hassan Ashktorab
Journal:  Mol Cancer       Date:  2008-08-21       Impact factor: 27.401

5.  Expression of the microtubule-associated protein MAP9/ASAP and its partners AURKA and PLK1 in colorectal and breast cancers.

Authors:  Sylvie Rouquier; Marie-Jeanne Pillaire; Christophe Cazaux; Dominique Giorgi
Journal:  Dis Markers       Date:  2014-04-30       Impact factor: 3.434
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.